IgA nephropathy in a patient with systemic lupus erythematosus

Lupus

Volumn 19, Issue 5, 2010, Pages 650-654

  Horino, T ^a   Takao, T ^a   Terada, Y ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin II receptor blocker; Angiotensin converting enzyme inhibitor; IgA nephropathy; Systemic lupus erythematosus

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DOUBLE STRANDED DNA ANTIBODY; FIBRINOGEN; IMMUNOGLOBULIN A; LOSARTAN; PREDNISOLONE; TEMOCAPRIL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; ELECTRON MICROSCOPY; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN A NEPHROPATHY; JAPANESE; KIDNEY BIOPSY; KNEE ARTHRITIS; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTOPENIA; MALE; PRIORITY JOURNAL; PROTEINURIA; RASH; RECURRENT DISEASE; REMISSION; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS;

GLOMERULONEPHRITIS, IGA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; YOUNG ADULT;

EID: 77951217439     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309349384     Document Type: Article

References (11)

1. Fine DM Pharmacological therapy of lupus nephritis. JAMA 2005 ; 293: 3053-3060.
2. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 ; 25: 1271-1277. (Pubitemid 13221242)
3. Basile C., Semeraro A., Montanaro A., et al. IgA nephropathy in a patient with systemic lupus erythematosus. Nephrol Dial Transplant 1998 ; 13: 1891-1892. (Pubitemid 28306845)
4. Fujikura E., Kimura T., Otaka A., et al. IgA nephropathy in the patient with systemic lupus erythematosus in remission. Nippon Naika Gakkai Zasshi 2002 ; 11: 3282-3284.
5. Mac-Moune Lai F., Li EKM, Tang NLS, Lui PKT, Lai KN IgA nephropathy: a rare lesion in systemic lupus erythematosus. Mod Pathol 1995 ; 8: 5-10.
6. Corrado A., Quarta L., Di Palma AM, Gesualdo L., Cantatore FP IgA nephropathy in systemic lupus erythematosus. Clin Exp Rheumatol 2007 ; 25: 467-469. (Pubitemid 47091028)
7. Prakash S., Kanjanabuch T., Austin PC, et al. Continental variations in IgA nephropathy among Asians. Clin Nephrol 2008 ; 70: 377-384.
8. Cattran DC, Greenwood C., Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 1994 ; 23: 247-254. (Pubitemid 24075319)
9. Gansevoort RT, De Zeeuw D. The antihypertensive and renal effects of angiotensin II receptor antagonist: Remaining questions. Curr Opin Nephrol Hypertens 2000 ; 9: 57-61. (Pubitemid 30041748)
10. Russo D., Minutolo R., Pisani A., et al. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis 2001 ; 38: 18-25. (Pubitemid 32611753)
11. Weening JJ, DAgati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004 ; 15: 241-250. (Pubitemid 38140764)